See also this year's filing and all EDGAR filings for this company.
PDF Report 0001411685_2017_Vistagen_Therapeutics_Inc.pdf
Logs
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001411685')"} |
Graph
Absolute values for 0001411685, Vistagen Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 855,300 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 87,600 |
| 3 | remainder_Assets | 46,900 |
| 4 | LiabilitiesCurrent | 1,794,700 |
| 5 | LiabilitiesNoncurrent | 2,172,300 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 13,918,600 |
| 9 | ResearchAndDevelopmentExpense | 3,931,600 |
| 10 | remainder_Expenses | 2,670,100 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -26,700,200 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 989,800 |
| 1 | Liabilities | 3,967,000 |
| 2 | Expenses | 20,520,300 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -2,977,200 |
| 5 | NetIncome | -47,220,500 |
| 6 | ComprehensiveNetIncome | -47,220,500 |
| 7 | BaseVar | 26,088,650 |
| 8 | EconomicCapitalRatio | -21.1 |
Edgar->Model Mapping
Feature Distribution
